Patient Brokering and California's Rehab Fraud Laws

By SoCal Addiction Centers Editorial Team | Last reviewed: | 14 min read Clinically Reviewed

Key Takeaways

  • Patient brokering is illegal in California under both state law (California Business and Professions Code §§650, 650.01–650.02 and related provisions, enforced through the Body Brokering and Patient Referral Integrity Act framework enacted via AB-2614 (Holden, 2018)) and federal law (EKRA — 18 U.S.C. § 220, enacted through the SUPPORT Act of 2018).
  • Federal EKRA filled a major gap in the federal Anti-Kickback Statute. AKS applied only to federally-funded healthcare programs (Medicare, Medicaid, Tricare); EKRA extended kickback criminalization to all addiction-treatment services regardless of payer, including private insurance.
  • California civil enforcement vectors include the Insurance Frauds Prevention Act (IFPA, Insurance Code §1871.7) with its whistleblower qui tam mechanism, the Unfair Competition Law (Business and Professions Code §17200), the Rosenthal Fair Debt Collection Practices Act, and other consumer-protection statutes.
  • Primary enforcement authorities in California include the US Attorneys for the Central and Southern Districts, FBI, DEA, HHS Office of Inspector General, California DOJ healthcare fraud unit, California Department of Insurance Fraud Division, and local District Attorneys’ offices.
  • Red flags families can identify: unsolicited recruitment by third parties, offers to waive deductibles or “handle” insurance informally, pressure to admit before completing facility evaluation, admission coordinators whose compensation isn’t transparent, referral relationships between sober living and a specific treatment facility that aren’t disclosed.
  • If you suspect patient brokering, the California Attorney General fraud complaint form, CDI Fraud Division, and HHS-OIG Hotline all accept public reports.

Patient brokering — what it is and why it’s illegal

Patient brokering is the payment or receipt of kickbacks — financial, in-kind, or otherwise valuable — in exchange for referring patients to addiction treatment facilities, clinical laboratories, recovery homes, or related services. The conduct is distinct from legitimate clinical referral (where clinicians recommend the clinically-appropriate care without financial interest in which facility receives the patient) and from transparent licensed-provider marketing. The distinguishing feature is the undisclosed per-referral remuneration that creates financial incentive to route patients based on payment rather than clinical need.

California’s SUD market experienced an extensive patient-brokering era from approximately 2015 through 2020, documented on our California Rehab Fraud Enforcement History page. The legal and regulatory framework responding to that conduct is the subject of this page. Both California state law and federal law criminalize patient brokering in addiction treatment; both civil and criminal enforcement authorities have standing to prosecute. The statutes are layered and interact; this page walks through each and how they apply in practice.

This is editorial guidance, not legal advice. For specific legal questions about a case or investigation, consult a California attorney familiar with healthcare fraud and addiction-treatment regulation.

California state law — the AB-2614 framework and related provisions

California’s state-law prohibition on patient brokering operates through several statutes working in combination.

AB-2614 (Holden, 2018) — the Body Brokering and Patient Referral Integrity Act was the principal modern California legislative response to patient brokering in addiction treatment. The bill amended provisions of the Business and Professions Code and related sections to clarify and strengthen prohibitions on per-referral payments in the SUD context.

Core prohibited conduct under California law:

  • Paying, offering to pay, soliciting, or receiving remuneration for referring a patient to an addiction treatment facility, recovery residence, clinical laboratory, or related service
  • Employing unlicensed “body brokers” or independent recruiters whose compensation is tied to patient admissions
  • Undisclosed kickback arrangements between SUD treatment providers and sober-living operators, physicians, clinical labs, or other referring parties
  • Waiving insurance deductibles or copays as an inducement for admission (a common patient-brokering pattern that also raises independent insurance-fraud concerns)

Criminal penalties under California law for patient brokering violations include fines and imprisonment; specific penalty levels vary by the provision charged and the nature of the conduct. Aggravated cases involving larger schemes, organized patient recruitment, or vulnerable-population exploitation carry enhanced exposure.

Business and Professions Code §§650, 650.01–650.02 are the longstanding California prohibitions on referral kickbacks that AB-2614 and related provisions extended and clarified for the SUD-treatment context. The healthcare-referral kickback prohibition has been part of California law for decades; the AB-2614 updates operationalized it specifically for the addiction-treatment market where patterns had evolved beyond what older provisions addressed cleanly.

California’s three-statute patient brokering framework (2018–2020)

California enacted a three-statute framework between 2018 and 2020 specifically responding to the Orange County rehab-fraud enforcement wave documented through federal and state prosecutions during that period. Each statute addressed a distinct gap in the pre-existing framework.

SB 1228 (Galgiani, 2017–2018) — the Substance Use Disorder Patient Protection Act. Signed by Governor Brown in September 2018. Added Part 4 commencing with Section 11977 to Division 10.5 of the California Health and Safety Code. SB 1228 was the primary California patient-brokering law operative during the 2015–2020 Orange County federal enforcement wave. Core provisions:

  • Defined patient brokering in the California SUD-treatment context
  • Prohibited licensees from referring patients to non-licensed or non-certified facilities
  • Established the DHCS certification program for recovery residences

AB-2614 (Dixon, Holden, 2018 and subsequent sessions) — the Body Brokering and Patient Referral Integrity Act. Passed in parallel with SB 1228 during the same legislative session, addressing patient-brokering conduct through amendments to Business and Professions Code provisions. Operates alongside SB 1228’s Health and Safety Code provisions; the two statutes together form the mid-2018 California state response to the enforcement environment.

SB 406 (Pan, 2020) — Health omnibus legislation that closed the final gap in California’s patient brokering enforcement architecture. SB 406 gave DHCS authority to refer patient-brokering complaints to federal authorities, state insurance departments, the California Attorney General, and the U.S. Attorney General for enforcement under EKRA and state insurance fraud laws. The referral authority enables DHCS-level investigations to hand off to enforcement authorities with criminal jurisdiction — previously a procedural gap that limited effective state-to-federal enforcement coordination.

Practical effect of the three-statute framework: California’s 2018–2020 legislative sequence created a patient brokering framework with (a) statutory definition and prohibition (SB 1228), (b) Business and Professions Code enforcement authority (AB-2614), and (c) DHCS-to-enforcement-authority referral mechanism (SB 406). Combined with federal EKRA (also 2018), the framework closed most of the pre-2018 enforcement gaps that enabled the Orange County fraud wave.

The framework exists; its practical effectiveness at deterring new patient-brokering conduct is an empirical question tracked through continued federal and state enforcement activity.

Federal law — EKRA and the AKS distinction

Federal Anti-Kickback Statute (AKS) — the longstanding framework

The federal Anti-Kickback Statute (AKS, 42 U.S.C. § 1320a-7b) has been federal law since 1972. It prohibits knowing and willful payment of remuneration to induce patient referrals, purchasing, leasing, ordering, or arranging for items or services reimbursed by federally-funded healthcare programs.

Key AKS limitation: the statute applies only to services paid for by federal programs — Medicare, Medicaid, Tricare, VA, Indian Health Service, and similar federally-funded healthcare payers. Services paid entirely by private insurance — the predominant payer category in California’s commercial SUD treatment market — were outside AKS’s direct reach.

This was the legal gap that enabled the 2015–2020 California patient-brokering enforcement challenges. Brokers, body brokers, and facility operators routing patients between commercial-insurance-covered residential treatment and sober-living homes were engaging in conduct that was morally equivalent to AKS violations but not directly prosecutable under AKS because the insurance payments didn’t flow through federal programs.

EKRA — the 2018 federal fix for the private-insurance gap

The Eliminating Kickbacks in Recovery Act (EKRA), codified at 18 U.S.C. § 220, was enacted as part of the SUPPORT for Patients and Communities Act signed October 24, 2018.

EKRA criminalizes knowing and willful payment or receipt of remuneration (direct or indirect, in cash or in kind) in exchange for referring a patient to a recovery home, clinical treatment facility, or laboratory for services covered by any healthcare benefit program — private insurance, self-pay, employer plans, anything. EKRA is payer-neutral; AKS was not.

Penalties under EKRA:

  • Fines up to $200,000 per occurrence
  • Imprisonment up to 10 years
  • Both
  • Additional penalties for repeat offenders or cases involving enhancers

EKRA applies in parallel with AKS when federal and private-insurance funds are both involved. Federal prosecutors can charge under AKS for the Medicare/Medicaid portion and EKRA for the private-insurance portion in a single scheme.

EKRA substantially closed the gap that enabled the 2015–2020 California enforcement challenges. Post-EKRA, federal prosecution of SUD patient brokering involving private insurance is operationally feasible in a way it wasn’t before.

EKRA safe harbors and unresolved questions

EKRA includes specific carve-outs for legitimate arrangements including certain employment relationships, managed care arrangements, and specific Medicare-regulated payment structures. The precise scope of EKRA’s safe harbors continues to develop through caselaw and Department of Justice interpretive guidance. Healthcare counsel familiar with EKRA is essential for providers navigating compliant referral and employment relationships.

California civil enforcement vectors

Beyond criminal prosecution, California offers multiple civil enforcement pathways for patient brokering and related fraud.

California Insurance Frauds Prevention Act (IFPA) — Insurance Code §1871.7

IFPA is California’s primary civil enforcement mechanism for insurance fraud, including the insurance-billing-fraud side of patient brokering schemes. The statute provides:

  • Civil penalties of $5,000 to $10,000 per fraudulent claim
  • Treble damages for actual losses
  • Attorneys’ fees for successful plaintiffs
  • Whistleblower qui tam provisions allowing private relators to file civil actions on behalf of the state

How IFPA qui tam actions work:

  1. A relator with knowledge of insurance fraud files a sealed complaint with the Attorney General or District Attorney
  2. The AG/DA investigates and decides whether to intervene
  3. If the state intervenes, prosecution proceeds under state authority
  4. If the state declines, the relator can pursue independently with state permission
  5. On successful recovery, the relator receives 30–50% of the recovery plus attorney’s fees (specific percentages in the statute)

IFPA qui tam has been a significant vehicle for SUD-industry fraud enforcement, often running in parallel with federal criminal cases against the same schemes.

California Unfair Competition Law (UCL) — Business and Professions Code §17200

The UCL provides a broad cause of action for “any unlawful, unfair or fraudulent business act or practice.” Patient brokering conduct — even where specific statutory violations are difficult to establish — may nonetheless be actionable under UCL as unfair or fraudulent business practice.

UCL actions can produce injunctive relief, restitution, and civil penalties. Standing is limited; plaintiffs must have suffered injury from the challenged practice. California AG and DA enforcement is the typical pathway rather than private plaintiff actions.

Rosenthal Fair Debt Collection Practices Act

California Civil Code §1788 et seq. regulates abusive debt collection practices. Rehab-billing fraud schemes sometimes involve abusive post-discharge collection practices against former patients; Rosenthal provides civil remedies for these practices.

Other consumer-protection statutes

California’s false advertising statute, elder abuse provisions, and various other consumer-protection provisions may apply to specific patient-brokering fact patterns.

Enforcement architecture

Patient brokering in California can be prosecuted by multiple authorities:

Federal:

  • US Attorneys for the Central District of California (LA, OC, SB, Ventura, and more) and Southern District of California (San Diego, Imperial)
  • FBI healthcare-fraud units
  • DEA for drug-distribution-related conduct
  • HHS Office of Inspector General for federal-program-related fraud
  • Department of Justice Consumer Protection Branch

California state:

  • California Department of Justice — Healthcare Fraud and Elder Abuse Section under the Attorney General
  • California Department of Insurance Fraud Division — specifically for insurance-fraud-adjacent patient brokering
  • Medi-Cal Fraud Control Unit — state-level Medi-Cal fraud enforcement

Local:

  • District Attorneys in LA, Orange, San Diego, Riverside, San Bernardino, and Ventura counties
  • County-level collaborative structures such as the historical Orange County Sober Homes Task Force documented on our fraud-history page

The multi-authority structure means a single patient-brokering investigation can involve federal criminal charges, federal civil actions, state criminal charges, IFPA qui tam civil action, UCL enforcement, and individual licensing-board actions against licensed professionals involved — potentially all arising from the same underlying conduct.

Typical patient-brokering schemes — what they look like

Understanding the common patterns helps families and patients recognize them:

Body broker recruitment — individuals (sometimes former patients, sometimes professional recruiters) paid per-admission commissions for directing patients to specific facilities. Common in OC’s 2015–2020 enforcement wave. Often operates across state lines.

Sober-living-to-residential cycling — an operator runs both a sober living home and a residential facility (or has an undisclosed referral arrangement with another facility). Patients admitted to residential, stepped down to sober living, then — under specific incentives — relapsed and re-admitted to residential. Insurance billing cycles through each re-admission.

Laboratory kickback arrangements — SUD facilities ordering excessive or unnecessary urinalysis testing from a specific clinical lab in exchange for per-test kickbacks. Some California cases have involved urinalysis billed at thousands of dollars per test when the service cost the lab a fraction of that.

Physician referral kickbacks — compensated arrangements between SUD facilities and physicians ordering unnecessary services. May involve kickbacks paid as consulting fees, honoraria, or similar arrangements designed to obscure the referral-based payment.

Insurance verification / “benefits handling” — facility staff or affiliated brokers “handle” insurance verification or offer to “waive deductibles” as admission inducements. The waived deductible — actually a disguised kickback — creates illegal inducement while also constituting insurance fraud.

Fraudulent clinical diagnosis — admissions teams coaching patients on how to present symptoms that trigger coverage, or manufacturing diagnostic presentations to obtain insurance authorization for services the patient doesn’t clinically need.

Our California Rehab Fraud Enforcement History page documents the historical trajectory of these patterns in the 2015–2020 California enforcement wave.

Red flags families and patients can identify

Without prosecutorial resources, families and patients can still spot warning signs:

  • Unsolicited outreach — a third party (not the patient’s own clinician or existing treatment relationship) reaches out offering facility admission, particularly if the third party frames themselves as an “admissions coordinator” operating independently
  • Pressure to commit before evaluating — admission-decision pressure before the patient has completed basic facility verification (DHCS license check, CARF accreditation check, independent insurance verification)
  • Offers to handle insurance informally or waive cost-sharing — “don’t worry about your deductible, we’ll work something out” — this pattern is both patient brokering and independently insurance fraud
  • Opaque facility ownership or referral relationships — the facility’s operator, the sober-living home it’s affiliated with, and any referring parties should be transparent; obscuring these relationships is a concern
  • Transport or housing “services” as admission inducement — free travel to the facility, free housing between admission decisions, free food and transportation — these can be legitimate but also a common broker-recruitment pattern
  • Referral from a “support group” or peer recovery contact whose compensation is not transparent — legitimate peer recovery support is paid through treatment providers or as employees; independent brokers are a red flag
  • Scripted responses to clinical questions — patients being coached on what to say to insurance benefits reviewers
  • Cross-country relocation pressure — a broker recruiting an East Coast or Midwest patient to California facilities may be operating on per-admission commissions

What to do if you suspect patient brokering

If you or someone you know has been approached through a patient brokering scheme, or you have observed such conduct:

  • Document what you observed — names, contact information, specific statements, dates, any physical evidence (promotional materials, communication records)

  • Do not engage with the suspected broker beyond documenting — the goal is evidence preservation, not personal confrontation

  • Report to appropriate authority:

  • If an IFPA qui tam action is potentially appropriate, consult with an attorney experienced in California insurance fraud qui tam litigation before proceeding. The sealed-complaint process has specific timing requirements.

Concerned about a specific facility or broker?

Our editorial team can help you identify red flags, verify a facility against public licensure and accreditation records, and direct you to the appropriate reporting authority if concerns rise to the level of suspected violation. We accept no referral fees from any facility discussed on this site. Calls are informational.

Contact our editorial team →

Need help now? Call (310) 596-1751 for editorial guidance. For formal complaints, use the authority contacts listed above. For immediate life-threatening situations, call 911.

Last reviewed: 2026-04-23. Statutory references reflect California and federal law at review date. Enforcement authority contact information reflects publicly-published channels. This page is editorial content on the patient-brokering legal framework, not legal advice or a complete enumeration of all applicable California statutes.

Looking for treatment options in your area? We can help point you in the right direction. (310) 596-1751 — or request a callback.